UK markets close in 1 hour 53 minutes

Evolent Health, Inc. (9EH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
25.40-0.40 (-1.55%)
As of 08:31AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 3.01B
Enterprise value 3.43B
Trailing P/E N/A
Forward P/E 19.96
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.57
Price/book (mrq)3.01
Enterprise value/revenue 1.75
Enterprise value/EBITDA -138.39

Trading information

Stock price history

Beta (5Y monthly) 1.54
52-week change 3-18.35%
S&P500 52-week change 323.57%
52-week high 332.40
52-week low 322.40
50-day moving average 329.28
200-day moving average 327.08

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5116.2M
Implied shares outstanding 6116.6M
Float 8109.07M
% held by insiders 13.97%
% held by institutions 1111.51%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -5.76%
Operating margin (ttm)1.23%

Management effectiveness

Return on assets (ttm)0.86%
Return on equity (ttm)-10.74%

Income statement

Revenue (ttm)1.96B
Revenue per share (ttm)17.65
Quarterly revenue growth (yoy)45.40%
Gross profit (ttm)N/A
EBITDA 127.5M
Net income avi to common (ttm)-142.26M
Diluted EPS (ttm)-1.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)192.82M
Total cash per share (mrq)1.69
Total debt (mrq)644.8M
Total debt/equity (mrq)51.74%
Current ratio (mrq)1.01
Book value per share (mrq)9.38

Cash flow statement

Operating cash flow (ttm)142.58M
Levered free cash flow (ttm)172.48M